Franziska Diekmann
Overview
Explore the profile of Franziska Diekmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hansmann G, Chouvarine P, Diekmann F, Giera M, Ralser M, Mulleder M, et al.
Nat Cardiovasc Res
. 2024 Aug;
1(6):568-576.
PMID: 39195868
Here we report application of human umbilical cord mesenchymal stem cell (HUCMSC)-derived therapy for pulmonary arterial hypertension (PAH). A 3-year-old female presented with heritable PAH associated with hereditary hemorrhagic telangiectasia...
2.
Jack T, Carlens J, Diekmann F, Hasan H, Chouvarine P, Schwerk N, et al.
Front Cardiovasc Med
. 2023 Jul;
10:1193326.
PMID: 37441704
Background: Bilateral lung transplantation (LuTx) remains the only established treatment for children with end-stage pulmonary arterial hypertension (PAH). Although PAH is the second most common indication for LuTx, little is...
3.
Wieland I, Diekmann F, Carlens J, Hinze L, Lambeck K, Jack T, et al.
Front Pediatr
. 2022 Dec;
10:1012738.
PMID: 36452355
Background And Objectives: Emerging evidence suggests that increased degradation of von Willebrand factor and decrease in high molecular weight multimers occurs in patients with pulmonary hypertension (PH). However, the link...
4.
Hasan H, Chouvarine P, Diekmann F, Diedrich N, Koestenberger M, Hansmann G
Eur J Clin Invest
. 2022 Jul;
52(11):e13835.
PMID: 35844040
Objectives: In 2019, the European Paediatric Pulmonary Vascular Disease Network (EPPVDN) developed a PH risk score to assess the risk and severity of pulmonary hypertension (PH) in children and young...
5.
Diekmann F, Legchenko E, Chouvarine P, Lichtinghagen R, Bertram H, Happel C, et al.
Front Cardiovasc Med
. 2021 Dec;
8:794549.
PMID: 34957265
Interleukin-7 (IL-7) secures B cell maturation, regulatory T and natural killer (NK) cell survival, and homeostasis, all of which are important for beneficial immunomodulation in pulmonary arterial hypertension (PAH). However,...
6.
Hansmann G, Diekmann F, Chouvarine P, Ius F, Carlens J, Schwerk N, et al.
J Heart Lung Transplant
. 2021 Dec;
41(2):187-198.
PMID: 34955331
Background: We investigated whether RV function recovers in children with pulmonary arterial hypertension (PAH) and RV failure undergoing lung transplantation (LuTx). Methods: Prospective observational study of 15 consecutive children, 1.9...
7.
Diekmann F, Chouvarine P, Sallmon H, Meyer-Kobbe L, Kieslich M, Plouffe B, et al.
Int J Mol Sci
. 2021 Aug;
22(16).
PMID: 34445297
Pulmonary arterial hypertension (PAH) is a progressive condition with an unmet need for early diagnosis, better monitoring, and risk stratification. The receptor for advanced glycation end products (RAGE) is activated...